Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04685070. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and Erlotinib
ClinicalTrials.gov study NCT00784667. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Sacituzumab Tirumotecan and Limertinib for Potentially Resectable Stage Ⅲ EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07323056. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination of Vebreltinib and Osimertinib in Patients with EGFR 21 L858R Mutation Advanced NSCLC
ClinicalTrials.gov study NCT06827145. IPD Sharing: NO. Countries: 1. Publications: 0.
Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.
ClinicalTrials.gov study NCT03992664. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04838548. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT06802835. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI
ClinicalTrials.gov study NCT03058094. IPD Sharing: NO. Countries: 1. Publications: 0.
Epidermal Growth Factor Receptor (EGFR) Status Based Gefitinib Neoadjuvant Therapy in Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00986284. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
ClinicalTrials.gov study NCT05810350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR T Cells in Treating Patients With Malignant Gliomas Overexpressing EGFR
ClinicalTrials.gov study NCT02331693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Furmonertinib in EGFR-Mutant, PD-L1+ Patients With Locally Advanced or Metastatic NSCLC (FUTURE)
ClinicalTrials.gov study NCT05255406. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Sma
ClinicalTrials.gov study NCT06970639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
ClinicalTrials.gov study NCT07074418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05573373. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR Molecular Classification In Vivo
ClinicalTrials.gov study NCT03031522. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ClinicalTrials.gov study NCT05642572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05017025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplifi
ClinicalTrials.gov study NCT02468661. IPD Sharing: NO. Countries: 10. Publications: 0.
Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03122717. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.